RESMED INC (RMD) Stock Income Statement
USA - New York Stock Exchange - NYSE:RMD - US7611521078 - Common Stock
252.13 USD
-3.7 (-1.45%)
| TTM (2025-9-30) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.26B | 5.15B | 4.69B | 4.22B | 3.58B | |||
| Cost Of Goods | 2.10B | 2.09B | 2.03B | 1.87B | 1.55B | |||
| Gross Profit | 3.16B | 3.05B | 2.66B | 2.36B | 2.02B | |||
| Operating Expenses | 1.40B | 1.37B | 1.27B | 1.20B | 1.02B | |||
| Research and Development | 339.08M | 331.28M | 307.52M | 287.64M | 253.57M | |||
| Selling, General, and Administrative Expenses | 1.01B | 991.02M | 917.14M | 874.00M | 739.37M | |||
| Operating Income | 1.76B | 1.69B | 1.38B | 1.15B | 1.00B | |||
| Interest Income/Expense | 2.93M | -2.54M | -51.60M | -44.72M | -43.00M | |||
| Other Income/Expense | -6.66M | -5.26M | -3.49M | -5.71M | 3.20M | |||
| Non Recurring Items | -16.33M | -519.00K | -64.23M | 101.00K | 0.00 | |||
| Income Before Taxes | 1.74B | 1.68B | 1.26B | 1.10B | 960.48M | |||
| Income Tax | 302.96M | 276.84M | 243.85M | 204.11M | 181.05M | |||
| Net Income | 1.44B | 1.40B | 1.02B | 897.56M | 779.44M | |||
| EBITDA | 1.95B | 1.88B | 1.56B | 1.32B | 1.19B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 9.77 | 9.51 | 6.92 | 6.09 | 5.30 | |||
| Non GAAP EPS | 9.90 | 9.55 | 7.73 | 6.45 | 5.79 | |||
| Statistics | ||||||||
| Gross Profit Margin | 60.05% | 59.33% | 56.67% | 55.78% | 56.57% | |||
| Profit Margin | 27.35% | 27.22% | 21.79% | 21.25% | 21.78% | |||
| Operating Profit Margin | 33.49% | 32.76% | 29.54% | 27.28% | 27.96% | |||
All data in USD